Evaluation of the anti-anginal efficacy and safety of ivabradine used in combination with an anti-anginal monotherapy in patients with stable effort angina pectoris. A 6-week, randomised, double-blind controlled, parallel-group, international, multicentre study.

Trial Profile

Evaluation of the anti-anginal efficacy and safety of ivabradine used in combination with an anti-anginal monotherapy in patients with stable effort angina pectoris. A 6-week, randomised, double-blind controlled, parallel-group, international, multicentre study.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Ischaemic heart disorder therapies; Ivabradine
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Sponsors Servier
  • Most Recent Events

    • 21 May 2012 Actual end date 31 May 2010 added as reported by Chinese Clinical Trial Register.
    • 18 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top